summary
Introduced
03/29/2021
03/29/2021
In Committee
05/09/2022
05/09/2022
Crossed Over
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
192nd General Court
Bill Summary
Relative to costs for treatment and management of diabetes. Financial Services.
AI Summary
This bill aims to limit the cost-sharing requirements for individuals with diabetes in Massachusetts. Specifically, it caps the deductible, copayment, or coinsurance for a 30-day supply of insulin at $25, a 30-day supply of prescribed oral diabetes medications that influence blood sugar levels at $50, and all other diabetes-related items at $100. The bill amends several sections of the Massachusetts General Laws, including chapters related to the state employee health insurance plan, Medicaid, private insurance, and health maintenance organizations (HMOs). This legislation is intended to improve affordability and access to essential diabetes treatment and management for residents of Massachusetts.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (17)
Pete Capano (D)*,
Michael Brady (D),
Linda Campbell (D),
Michelle Ciccolo (D),
Marcos Devers (D),
Mindy Domb (D),
Jessica Giannino (D),
Natalie Higgins (D),
David LeBoeuf (D),
Jack Lewis (D),
Elizabeth Malia (D),
Patrick O'Connor (R),
Steve Owens (D),
Lindsay Sabadosa (D),
Dan Sena (D),
Paul Tucker (D),
Steve Ultrino (D),
Last Action
Accompanied a study order, see H5222 (on 09/15/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/192/H1055 |
| Bill | https://malegislature.gov/Bills/192/H1055.pdf |
Loading...